Gene · 92521
NIH grants1,071
NIH grants whose papers are about the gene, through NIH's grant-paper links.
501 to 520 of 1,071
Download this page as JSON| Grant | Title | SPECC1 papers | Newest fiscal year |
|---|---|---|---|
| R01AI136511 | Chromatin structure and control of gene expression in the human malaria parasite | 1 | 2022 |
| R01AI137472 | Rational design and evaluation of novel mRNA vaccines against MERS-CoV | 1 | 2022 |
| R01AI139092 | Structure-based design of coronavirus subunit vaccines | 1 | 2022 |
| R01AI140705 | SFTSV nonstructural protein NSs-mediated immunopathogenesis | 1 | 2022 |
| R01AI140970 | HIV Evolution Defines Virus-Host/Drug Interactions In Viremic and Aviremic People | 1 | 2022 |
| R01AI142743 | RAPs-mediated post-transcriptional control in Apicomplexan parasites | 1 | 2022 |
| R01CA210929 | Define redundant functions of H2AX and NBS1 in DNA repair | 1 | 2022 |
| R01CA216437 | 53BP1-dependent pathway in DNA repair | 1 | 2022 |
| R01DK117940 | Thyroid Hormone Signaling in Human Hepatocytes | 1 | 2022 |
| R01EB028095 | Development of a 3D multi-modal perfusion-thermal electrode system | 1 | 2022 |
| R01ES029212 | Placental Functional Networks Linking Developmental Pesticide Exposure and Offspring Neurodevelopment | 1 | 2022 |
| R01ES029280 | Environmental Exposures, AHR Activation, and Placental Origins of Development | 1 | 2022 |
| R01GM066099 | Functional Determinants in G-Protein-Coupled Receptors | 1 | 2022 |
| R01GM127575 | Develop General Methods for the Synthesis of Proteins with Posttranslational Lysine Modifications | 1 | 2022 |
| R01GM129090 | Defining Pathway-Specific Kinase Signaling Modules with Proteomics | 1 | 2022 |
| R01GM129431 | Structure, Mechanism, and Regulation of PACAP/VIP GPCR subtypes | 1 | 2022 |
| R01GM130915 | Origin of N-Glycan Site-Specific Heterogeneity | 1 | 2022 |
| R01GM132565 | Principles for Designing Stimulus-Responsive Enzymes | 1 | 2022 |
| R01GM132595 | Reproducible, Unbiased Ligand Identification Assisted by Artificial Intelligence and Development of Ligand Reference Libraries | 1 | 2022 |
| R01GM132826 | A MULTISCALE APPROACH TO TARGET THE ACHILLES HEEL OF P53 CANCER MUTANTS | 1 | 2022 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/grants?page=26